Phototoxic drug reaction with the novel agent rovalpituzumab tesirine

Saved in:
Bibliographic Details
Published inInternational journal of dermatology Vol. 57; no. 3; pp. e17 - e19
Main Authors Hou, Jennifer L., Bridges, Alina G.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.03.2018
Subjects
Administration, Topical
Adult
Antibodies, Monoclonal, Humanized - adverse effects
Antibodies, Monoclonal, Humanized - therapeutic use
Benzodiazepinones - adverse effects
Benzodiazepinones - therapeutic use
Biopsy, Needle
Carcinoma, Hepatocellular - drug therapy
Carcinoma, Hepatocellular - pathology
Clobetasol - therapeutic use
Dermatitis, Phototoxic - drug therapy
Dermatitis, Phototoxic - etiology
Dermatitis, Phototoxic - pathology
Drug Eruptions - etiology
Drug Eruptions - pathology
Female
Follow-Up Studies
Humans
Hydrocortisone - therapeutic use
Immunoconjugates - adverse effects
Immunoconjugates - therapeutic use
Immunohistochemistry
Liver Neoplasms - drug therapy
Liver Neoplasms - pathology
Treatment Outcome
Online AccessGet full text

Cover

More Information
ISSN:0011-9059
1365-4632
DOI:10.1111/ijd.13836